by Annie De Groot | Mar 28, 2019 | Events
Frontiers in Cancer Immunotherapy Symposium Tuesday, May 14th – Wednesday, May 15th Registration starts at 8:30A.M. on Tuesday The New York Academy of Sciences 7 World Trade Center New York City, New York Meet EpiVax Oncology’s CEO/Co-Founder, Gad Berdugo,...
by Annie De Groot | Mar 28, 2019 | News
THIS ORIGINAL ARTICLE WAS PUBLISHED IN PR NEWSWIRE. LINK TO THE ORIGINAL ARTICLE CAN BE FOUND HERE. NEW YORK, March 25, 2019 /PRNewswire/ — EpiVax Oncology, Inc., a precision cancer immunotherapy company, today announced that its abstract has been selected for...
by Annie De Groot | Mar 5, 2019 | Events
American Association for Cancer Research (AACR) Annual MeetingFriday, March 29th – Wednesday, April 3rdGeorgia World Congress CenterAtlanta, GeorgiaThank you to everyone who attended Dr. Richard’s presentation at AACR 2019. We hope you learned something...
by Annie De Groot | Mar 1, 2019
2018 Design of Cancer Immunotherapies – Selection of Neo-Epitopes, Removal of Tregitopes
by Annie De Groot | Mar 1, 2019
2017 Ancer An Innovative Cancer Neoantigen Prediction System
by Annie De Groot | Oct 8, 2018
EpiVax_poster_Disease Status Explained by Neo-Epitopes with Low Potential for Activating Regulatory T Cells
by Annie De Groot | Oct 8, 2018
EpiVax_Ancer_CICON_Application of Precision Cancer Immunotherapy Design Tools to Bladder Cancer_26Sep18
by Annie De Groot | Oct 5, 2018
EpiVax_ISV2018_CT26_01Oct18_50Wx36H
by Annie De Groot | Dec 3, 2017 | Thinking Out Loud -Blog
So, you say, why not? Why wait for Gritstone, BioNtec, Neon or even EpiVax Oncology when you can just DIY? If you can now sequence your own cancer mutanome (for about $5,000), and predict your own mutated epitopes using online tools, why not? Some cancer patients are...